PUBLIC COMPANY
save$IMUXIMMUNIC, INC.
$IMUXNew York, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
- phase3Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
- phase3A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)
- phase2Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
- phase2MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)
- phase2Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
- phase1IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that